- Daiichi Sankyo, Inc. (Bernards, NJ)
- …as other research areas centered around rare diseases and immune disorders. Summary The Associate Director , Global Oncology Medical Affairs, Medical ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …research areas centered around rare diseases and immune disorders. SummaryThe Director Global Medical Affairs Oncology (GMA), ADC, under the direction of ... the Senior Director , GMA Oncology ADC ( Global Medical Affairs team lead for compound), is responsible for assisting with defining compound/program … more
- Merck & Co. (Rahway, NJ)
- Job DescriptionOur company is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. The difference ... and an inspiring mission to achieve new milestones in global healthcare. Our Company is on a quest for...changes the way we approach serious diseases. --The Senior Director will report to an Associate Vice President in… more
- Merck & Co. (Rahway, NJ)
- Job DescriptionOur Business Development & Licensing organization is a global team comprising professionals who specialize in areas such as search & evaluation, ... external partnerships that grow our portfolio in meaningful ways. - The Director , Business Development & Licensing - Enabling Technologies Search and Evaluation,… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …compound under the supervision and leadership of the Executive Director of Medical Research and Strategy, US Oncology Medical Affairs (USOMA). Develops ... diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology...Launch Readiness activities and life cycle management from a medical perspective- Participates in Global Medical… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... cross-functional partners and if applicable, Alliance counterparts.Responsibilities- Partners with US Medical Affairs Oncology and stakeholders in Daiichi Sankyo… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... and aligned strategy.Responsibilities:Operational Strategy and Oversight:Align with the Senior Director , Global Clinical Operations on plans for successful… more
- Eisai, Inc (Nutley, NJ)
- …and make a difference. If this is your profile, we want to hear from you. The Oncology US Medical Excellence and Training role will work closely with Global ... Medical Education and Training colleagues and with the Global & US MALT ( Medical Affairs Leadership...medical affairs/ excellence, or related and relevant function. Oncology disease management knowledge in the therapeutic areas of… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Eisai, Inc (Nutley, NJ)
- At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai's human health care ... We're a growing pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development. Our history includes… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Eisai, Inc (Nutley, NJ)
- …input to the health economics and outcomes research strategies, and timelines with medical affairs, marketing, managed markets and global value and access teams. ... At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides...pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development.… more
- Eisai, Inc (Nutley, NJ)
- At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai's human health care ... pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development....profile, we want to hear from you. The Associate Director , Compliance Operations will be a key member of… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …initiatives for continuous quality improvement.Deputize for the Sr. Director , Medical Affairs QA as needed. Cross-functional and Global Team ... diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology...and immune disorders. Job Summary: Reporting to the Sr. Director , Medical Affairs QA, the Director… more
- Eisai, Inc (Nutley, NJ)
- At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai's human health care ... We're a growing pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development. Our history includes… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... is primarily focused on providing novel therapies in oncology , as well as other research areas centered around...with License Partners, Patient Support Programs, Market Research vendors, Global Quality Supply Chain, Medical Information Social… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...around rare diseases and immune disorders. Summary The Executive Director , Data Management (Head of Global Data… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...disorders. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology… more
